Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial

MeSH terms

• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use*
• Cladribine / administration & dosage
• Cladribine / therapeutic use*
• Follow-Up Studies
• Humans
• Lymphoma, B-Cell / drug therapy*
• Lymphoma, B-Cell, Marginal Zone / drug therapy*
• Remission Induction
• Survival Analysis